Santen Pharmaceutical Co., Ltd.

Overview

Santen Pharmaceutical Co., Ltd. is a global company specializing in research, development, and marketing of ophthalmic products. With a focus on eye care, the company is dedicated to improving patients' quality of life and contributing to the advancement of ophthalmology worldwide.

Therapeutic areas

API / Drug Master Files

Santen Pharmaceutical Co., Ltd. holds 0 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CS-011 DRUG SUBSTANCEInactive1999-07-29
• MANUFACTURING PLANT AT NOTO, JAPANInactive1994-06-03
• RIMATILInactive1992-03-19
• TROPICAMIDE MYDRIATICInactive1983-05-11
• THIOLAInactive1979-02-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Santen Pharmaceutical Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.